Drawing for HLS THERAPEUTICS

USPTO serial 86515140

HLS THERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 5796674Status 710
Filing date
Status date
Registration date
Jul 9, 2019
Examiner
CALLAGHAN, BRIAN P
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with HLS THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Megan K. Bowen

Megan K. Bowen Morgan, Lewis & Bockius LLP1111 Pennsylvania Avenue, NWAttn: TMSUWashington, DC 20004

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes, cardiovascular disorders, central nervous system (CNS) disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, respiratory, gastrointestinal and other metabolic disorders, namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, osteoporosis and other bone disorders, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, immunomodulatory diseases, namely, autoimmune diseases, immunologic deficiency syndromes; and antidepressants, antivirals, antibacterial pharmaceuticals, antifungal preparations, anti-inflammatories, analgesics and other pain therapeutics, namely, pain relief medications in the nature of muscle relaxants, anti-anxiety and anti-convulsion medications and acetaminophen, pharmaceutical preparations to treat diseases of the genitourinary system in women, hormones, namely, progesterone, progestins, and estrogens, hormone receptor modulators, and osteoporosis medicinesSECTION 8 - CANCELLED—
042Pharmaceutical drug formulation development; clinical evaluation and testing in the nature of conducting clinical trials relating to pharmaceuticalsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 23, 2026C8..CANCELLED SEC. 8 (6-YR)—
Sep 10, 2025ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 9, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 9, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 4, 2019DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Jun 4, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 20, 2019IUCNNOTICE OF ALLOWANCE CANCELLED—
May 20, 2019EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Apr 13, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 11, 2019EX1GSOU EXTENSION 1 GRANTED—
Apr 11, 2019EXT1SOU EXTENSION 1 FILED—
Apr 11, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 16, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 12, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Aug 22, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Aug 21, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 21, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 1, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 16, 2018FIXDELECTRONIC RECORD REVIEW COMPLETE—
Jul 13, 2018ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jul 9, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 9, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Jul 9, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 9, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 9, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 24, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 24, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 24, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 2, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 2, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 18, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jun 19, 2017GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jun 19, 2017GNSIINQUIRY TO SUSPENSION E-MAILED—
Jun 19, 2017CNSISUSPENSION INQUIRY WRITTEN—
Jun 19, 2017RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Dec 16, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 16, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Dec 16, 2016CNSLSUSPENSION LETTER WRITTEN—
Jun 24, 2016GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jun 24, 2016GNSIINQUIRY TO SUSPENSION E-MAILED—
Jun 24, 2016CNSISUSPENSION INQUIRY WRITTEN—
Jun 23, 2016RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Dec 22, 2015GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 22, 2015GNSLLETTER OF SUSPENSION E-MAILED—
Dec 22, 2015CNSLSUSPENSION LETTER WRITTEN—
Dec 1, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 1, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 30, 2015ALIEASSIGNED TO LIE—
Nov 6, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 12, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 12, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 7, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 7, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 7, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 1, 2015DOCKASSIGNED TO EXAMINER—
Feb 5, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 30, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance